new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)


Biogen Ma Inc patents

Recent patent applications related to Biogen Ma Inc. Biogen Ma Inc is listed as an Agent/Assignee. Note: Biogen Ma Inc may have other listings under different names/spellings. We're not affiliated with Biogen Ma Inc, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "B" | Biogen Ma Inc-related inventors

Date Biogen Ma Inc patents (updated weekly) - BOOKMARK this page
05/11/17Cross-scale modeling of bioreactor cultures using raman spectroscopy
04/27/17Inhibitors of bruton's tyrosine kinase
04/27/17Methods of increasing protein production in mammalian cells
03/30/17Wearable medical detector
03/30/17Compositions and methods for modulation of smn2 splicing
03/23/17Gas delivery devices and associated systems and methods
03/16/17Factor viii chimeric proteins and uses thereof
02/23/17Polyalkylene polymer compounds and uses thereof
02/16/17Compositions and methods for modulation of smn2 splicing in a subject
02/09/17Sp35 antibodies and uses thereof
02/02/17Heterocyclic tyrosine kinase inhibitors
02/02/17Anti-bcma antibodies
02/02/17Medium supplements for improved process performance
01/19/17Method of assessing risk of pml
01/05/17Dimethyl fumarate and vaccination regimens
12/29/16Bruton's tyrosine kinase inhibitors
12/22/16Compositions comprising antibodies to lingo or fragments thereof
12/15/16Method for delivering interferon-beta
12/08/16Methods for treating pressure induced optic neuropathy, preventing neuronal degeneration and promoting neuronal cell survival via administration of lingo-1 antagonists and trkb agonists
12/01/16Use of cation-exchange chromatography in the flow-through mode to enrich post-translational modifications
12/01/16On-column viral inactivation methods
11/03/16Infusion pump drive with compression spring
11/03/16Biaryl bruton's tyrosine kinase inhibitors
10/27/16Controlled release dosage form for once daily administration of dimethyl fumarate
10/27/16Biaryl inhibitors of bruton's tyrosine kinase
10/27/16Recombinant factor viii proteins
10/20/16Population pharmacokinetics tools and uses thereof
10/20/16Apparatus and related method to facilitate testing via a computing device
10/20/16Pyrimidinyl tyrosine kinase inhibitors
10/20/16Control of protein glycosylation by culture medium supplementation and cell culture process parameters
10/20/16Population pharmacokinetics tools and uses thereof
10/06/16Procoagulant fusion compound
10/06/16Use of perfusion seed cultures to improve biopharmaceutical fed-batch production capacity and product quality
10/06/16Method for distribution of a drug
09/22/16Anti-vla-4 related assays
09/08/16Drug delivery dose indicator
09/01/16Neuroprotection in demyelinating diseases
09/01/16Polymer conjugates of interferon beta-1a and uses
09/01/16Thrombin cleavable linker with xten and its uses thereof
08/25/16Tweak antagonists for treating lupus nephritis and muscle atrophy
08/18/16Control of protein glycosylation by culture medium supplementation and cell culture process parameters
08/11/16Treatment of melanoma with interferon-beta and ras-raf-mek-erk inhibitor combination therapy
08/11/16Transgenic animals for in vivo imaging
08/11/16Thrombin cleavable linker
07/28/16Use of lingo-4 antagonists in the treatment of conditions involving demyelination
07/14/16Factor viii-xten fusions and uses thereof
06/30/16Purification of chimeric fviii molecules
06/30/16Antibodies against monocyte chemotactic proteins
06/30/16Assay for jc virus antibodies
06/09/16Nogo receptor antagonists
06/02/16Compositions and methods for the treatment of progressive multifocal leukoencephalopathy (pml)
06/02/16Compositions and methods for treatment of stroke
05/19/16Oncostatin m receptor antigen binding proteins
05/12/16Bicyclic aryl sphingosine 1-phosphate analogs
05/12/16Anti-factor viii antibodies or uses thereof
05/12/16Methods of evaluating cell culture additives
04/28/16Anti-gpiib/iiia antibodies or uses thereof
04/28/16Chimeric fvii-xten molecules and uses thereof
04/28/16Prodrugs and drugs
04/28/16Method of assessing risk of pml
03/24/16Compositions comprising antibodies to lingo or fragments thereof
02/18/16Biomarkers predictive of therapeutic responsiveness to ifnb and uses thereof
02/11/16S1p and/or atx modulating agents
02/11/16Systems and methods for characterization of multiple sclerosis
02/04/16Assessment of labeled probes in a subject
Patent Packs
02/04/16Compositions and methods for assessing neuromuscular function
02/04/16Anti-alpha v beta 6 antibodies and uses thereof
01/28/16Hydrophobic interaction protein chromatography under no-salt conditions
01/28/16Use of raman spectroscopy to monitor culture medium
01/21/16Treatment and prevention of acute kidney injury using anti-alpha v beta 5 antibodies
01/21/16Anti-alpha v beta 6 antibodies and uses thereof
01/14/16Arginine inactivation of viruses
01/07/16Factor ix polypeptide formulations
01/07/16Macrocyclic compounds as irak4 inhibitors for the treatment of inflammatory diseases
01/07/16Treatment of conditions involving demyelination
01/07/16High resolution melting analysis assay for the detection of viral dna
12/24/15Nrf2 screening assays and related methods and compositions
12/17/15S1p modulating agents
12/17/15Optimized factor viii gene
12/17/15Assay for detection of jc virus dna
Patent Packs
12/10/15Medium supplements for improved process performance
12/03/15Human anti-tau antibodies
11/19/15Use of dr6 antagonists to improve motor neuron disease
11/05/15Sp35 antibodies and uses thereof
10/22/15Antibodies to vla-1
10/22/15Anti-blood dendritic cell antigen 2 antibodies and uses thereof
10/01/15Methods of preventing and removing trisulfide bonds
09/24/15Factor viii complex with xten and von willebrand factor protein, and uses thereof
07/30/15Pharmaceutical compositions containing dimethyl fumarate

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009


This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. is not affiliated or associated with Biogen Ma Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Biogen Ma Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by